Lesley Ann Kane

Title: Lesley Ann Kane: Innovator in Anti-Tau Antibodies

Introduction

Lesley Ann Kane is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of anti-Tau antibodies. Her work is crucial in understanding and potentially treating neurodegenerative diseases.

Latest Patents

Lesley Ann Kane holds a patent for "Anti-Tau antibodies and methods of use thereof." This patent includes antibodies that specifically bind to human Tau protein. In various embodiments, her anti-Tau antibodies recognize specific epitopes within the full-length human Tau protein, including residues 111-125, 251-270, and 346-360. Additionally, her antibodies can bind to both phosphorylated and unphosphorylated forms of human Tau, as well as multiple splice isoforms. The patent also discusses the inclusion of modified Fc polypeptides in the anti-Tau antibodies.

Career Highlights

Kane's career is marked by her innovative research and development in the field of antibodies. She has been instrumental in advancing the understanding of Tau proteins and their implications in neurodegenerative diseases. Her work at Denali Therapeutics Inc. showcases her commitment to scientific advancement and therapeutic development.

Collaborations

Lesley Ann Kane has collaborated with notable colleagues, including Xiaocheng Chen and Mark S. Dennis. These collaborations have further enhanced her research and contributed to the success of her projects.

Conclusion

Lesley Ann Kane is a distinguished inventor whose work on anti-Tau antibodies has the potential to impact the treatment of neurodegenerative diseases significantly. Her contributions to biotechnology continue to pave the way for future innovations in the field.